A Phase 1, Randomized, Open‐Label, Safety, Tolerability, and Comparative Bioavailability Study of Intranasal Dihydroergotamine Powder (STS101), Intramuscular Dihydroergotamine Mesylate, and Intranasal DHE Mesylate Spray in Healthy Adult Subjects
Sign Up to like & getrecommendations! Published in 2020 at "Headache"
DOI: 10.1111/head.13737
Abstract: To investigate and compare the safety and the pharmacokinetics of dihydroergotamine (DHE) after administration of intranasal DHE powder (STS101), intranasal DHE spray (Migranal®), and intramuscular (IM) DHE injection in healthy subjects. read more here.
Keywords: dihydroergotamine; powder sts101; intranasal dhe; mesylate ... See more keywords